Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Merck KGaA to Acquire Bio-Techne Corporation for US$11.3 Billion
Sidley Austin LLP has advised Bio-Techne Corporation. Sullivan & Cromwell LLP and Freshfieds have advised Merck KGaA, Darmstadt, Germany. Linklaters has advised BNP Paribas, Deutsche Bank...
Opus Genetics Secures $155 Million Structured Financing from Oberland Capital
Sidley has advised Opus Genetics on the deal. Opus Genetics, Inc., a clinical-stage gene therapy company focused on inherited retinal diseases, has entered into a strategic...
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
Axsome Therapeutics Acquires Global Rights to Balipodect from Takeda
Sidley has advised Axsome Therapeutics. White & Case has advised Takeda Pharmaceutical Company Limited. Axsome Therapeutics, Inc. (Nasdaq: AXSM) has acquired exclusive global rights to TAK-063...
Verdane Acquires Majority Stake in Smartbox Group to Accelerate AAC Technology Expansion
Burges Salmon and Shaw & Co have advised the management team of Smartbox Group. Sidley and Travers Smith have advised Verdane. Smartbox Group has entered a...
Precision NeuroMed and Brainlab Announce Strategic Partnership for AI-Enabled Brain Drug Delivery Platform
Sidley has advised Precision NeuroMed Inc. on the deal. Precision NeuroMed Inc. (PNM), a clinical-stage biotechnology company, has entered a strategic partnership with Brainlab SE, a...
Simcere and Boehringer Ingelheim Enter €1.05 Billion Licensing and Collaboration Agreement for Preclinical IBD Treatment
Sidley has advised Simcere Pharmaceutical Group Ltd. on the deal. Simcere Pharmaceutical Group Ltd. has entered into a licensing and collaboration agreement with Boehringer Ingelheim valued...
Smith+Nephew Acquires Integrity Orthopaedics in US$450 Million Deal
Sidley has advised Smith+Nephew. Smith+Nephew (LSE: SN, NYSE: SNN), a global medical technology company,, has entered into an agreement to acquire Integrity Orthopaedics, a U.S.-based sports...
Immunovant Raises $550 Million in Common Stock Offering
Sidley Austin LLP has advised Immunovant, Inc. Latham & Watkins LLP has advised the underwriter. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on developing...
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
Immuneering Prices $175 Million Public Offering and $25 Million Private Placement
Latham & Watkins has advised Immuneering Corporation on the offering, and Sidley Austin has advised Leerink Partners and Oppenheimer & Co. Immuneering Corporation has announced the...